These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Role of recombinant interleukin-2 in combination with interferon-alfa and chemotherapy in the treatment of advanced melanoma. Legha SS; Buzaid AC Semin Oncol; 1993 Dec; 20(6 Suppl 9):27-32. PubMed ID: 8054006 [No Abstract] [Full Text] [Related]
27. Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies. Antel JP; Miron VE Clin Neurol Neurosurg; 2008 Nov; 110(9):951-7. PubMed ID: 18502570 [TBL] [Abstract][Full Text] [Related]
28. Retinopathy in a multiple sclerosis patient undergoing interferon-therapy. Saito H; Suzuki M; Asakawa T; Kato S Mult Scler; 2007 Aug; 13(7):939-40. PubMed ID: 17468441 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic role of beta-interferons in multiple sclerosis. Javed A; Reder AT Pharmacol Ther; 2006 Apr; 110(1):35-56. PubMed ID: 16229894 [TBL] [Abstract][Full Text] [Related]
31. Letter: Acute effects of oral phosphate on visual function in multiple sclerosis. Ellenberger C Neurology; 1975 Feb; 25(2):97-8. PubMed ID: 1167650 [No Abstract] [Full Text] [Related]
32. Effective combination of minocycline and interferon-beta in a model of multiple sclerosis. Giuliani F; Fu SA; Metz LM; Yong VW J Neuroimmunol; 2005 Aug; 165(1-2):83-91. PubMed ID: 15958276 [TBL] [Abstract][Full Text] [Related]
36. [The role of interferon beta in the treatment of multiple sclerosis]. Seeldrayers P Rev Med Brux; 1999 Sep; 20(4):A264-7. PubMed ID: 10523902 [TBL] [Abstract][Full Text] [Related]